Janssen Biotech signs deal to buy Maryland immunotherapy company By: Philadelphia Business Journal via Business Journals May 02, 2018 at 13:13 PM EDT The deal expands the Johnson & Johnson subsidairy’s onco-immunology presence. Financial terms of the deal are being kept confidential Read More >>